Influence of olsalazine on gastrointestinal transit in ulcerative colitis

Satish Sanku Chander Rao, N. W. Read, C. D. Holdswortii

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

the effect of olsalazine on stool output and the transit of a solid radiolabelled meal through the stomach, small intestine and colon was studied in six patients with ulcerative colitis intolerant of sulphasalazine. Olsalazine 250 mg four times daily significantly accelerated gastric emptying (mean±sd; 45·3±24·2 min v 67·3± 33·1 min, p<0·05), mouth to caecum transit time (242±41 min i, 325+33 min, p<0·02) and whole gut transit time (6(05±26 h v 37·8±17·8 h, P<0·05). No significant changes were seen in mean daily stool weight (215±41 g v 162±62 g) and Mean daily stool frequency (2·2±0·6 v 2·4± 1·8). None of these patients developed diarrhoea, but Acceleration of gastric and intestinal transit m'ay be responsible for the diarrhoea reported in some patients taking this drug.

Original languageEnglish (US)
Pages (from-to)1474-1477
Number of pages4
JournalGut
Volume28
Issue number11
DOIs
StatePublished - Jan 1 1987

Fingerprint

Gastrointestinal Transit
Ulcerative Colitis
Diarrhea
Stomach
Sulfasalazine
Gastric Emptying
Small Intestine
Meals
Mouth
Colon
Weights and Measures
Pharmaceutical Preparations
olsalazine

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Influence of olsalazine on gastrointestinal transit in ulcerative colitis. / Rao, Satish Sanku Chander; Read, N. W.; Holdswortii, C. D.

In: Gut, Vol. 28, No. 11, 01.01.1987, p. 1474-1477.

Research output: Contribution to journalArticle

Rao, Satish Sanku Chander ; Read, N. W. ; Holdswortii, C. D. / Influence of olsalazine on gastrointestinal transit in ulcerative colitis. In: Gut. 1987 ; Vol. 28, No. 11. pp. 1474-1477.
@article{b8558d2ebc694b9a9a1a60fd885d1556,
title = "Influence of olsalazine on gastrointestinal transit in ulcerative colitis",
abstract = "the effect of olsalazine on stool output and the transit of a solid radiolabelled meal through the stomach, small intestine and colon was studied in six patients with ulcerative colitis intolerant of sulphasalazine. Olsalazine 250 mg four times daily significantly accelerated gastric emptying (mean±sd; 45·3±24·2 min v 67·3± 33·1 min, p<0·05), mouth to caecum transit time (242±41 min i, 325+33 min, p<0·02) and whole gut transit time (6(05±26 h v 37·8±17·8 h, P<0·05). No significant changes were seen in mean daily stool weight (215±41 g v 162±62 g) and Mean daily stool frequency (2·2±0·6 v 2·4± 1·8). None of these patients developed diarrhoea, but Acceleration of gastric and intestinal transit m'ay be responsible for the diarrhoea reported in some patients taking this drug.",
author = "Rao, {Satish Sanku Chander} and Read, {N. W.} and Holdswortii, {C. D.}",
year = "1987",
month = "1",
day = "1",
doi = "10.1136/gut.28.11.1474",
language = "English (US)",
volume = "28",
pages = "1474--1477",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",
number = "11",

}

TY - JOUR

T1 - Influence of olsalazine on gastrointestinal transit in ulcerative colitis

AU - Rao, Satish Sanku Chander

AU - Read, N. W.

AU - Holdswortii, C. D.

PY - 1987/1/1

Y1 - 1987/1/1

N2 - the effect of olsalazine on stool output and the transit of a solid radiolabelled meal through the stomach, small intestine and colon was studied in six patients with ulcerative colitis intolerant of sulphasalazine. Olsalazine 250 mg four times daily significantly accelerated gastric emptying (mean±sd; 45·3±24·2 min v 67·3± 33·1 min, p<0·05), mouth to caecum transit time (242±41 min i, 325+33 min, p<0·02) and whole gut transit time (6(05±26 h v 37·8±17·8 h, P<0·05). No significant changes were seen in mean daily stool weight (215±41 g v 162±62 g) and Mean daily stool frequency (2·2±0·6 v 2·4± 1·8). None of these patients developed diarrhoea, but Acceleration of gastric and intestinal transit m'ay be responsible for the diarrhoea reported in some patients taking this drug.

AB - the effect of olsalazine on stool output and the transit of a solid radiolabelled meal through the stomach, small intestine and colon was studied in six patients with ulcerative colitis intolerant of sulphasalazine. Olsalazine 250 mg four times daily significantly accelerated gastric emptying (mean±sd; 45·3±24·2 min v 67·3± 33·1 min, p<0·05), mouth to caecum transit time (242±41 min i, 325+33 min, p<0·02) and whole gut transit time (6(05±26 h v 37·8±17·8 h, P<0·05). No significant changes were seen in mean daily stool weight (215±41 g v 162±62 g) and Mean daily stool frequency (2·2±0·6 v 2·4± 1·8). None of these patients developed diarrhoea, but Acceleration of gastric and intestinal transit m'ay be responsible for the diarrhoea reported in some patients taking this drug.

UR - http://www.scopus.com/inward/record.url?scp=0023626480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023626480&partnerID=8YFLogxK

U2 - 10.1136/gut.28.11.1474

DO - 10.1136/gut.28.11.1474

M3 - Article

C2 - 3428673

AN - SCOPUS:0023626480

VL - 28

SP - 1474

EP - 1477

JO - Gut

JF - Gut

SN - 0017-5749

IS - 11

ER -